CRISPR screens and quantitative proteomics reveal remodeling of the aryl hydrocarbon receptor–driven proteome through PARP7 activity

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2424985122
Affiliations:
8
Authors:
14
Go to article
Institutions Authors Share
AstraZeneca Cambridge, United Kingdom (UK)
4.000000
 0.29
University of Oxford, United Kingdom (UK)
3.500000
 0.25
Harvard Medical School (HMS), United States of America (USA)
3.000000
 0.21
NIH NCI Center for Cancer Research (CCR), United States of America (USA)
1.000000
 0.07
Hull York Medical School (HYMS), United Kingdom (UK)
1.000000
 0.07
University Hospital Duesseldorf (UKD), Germany
0.500000
 0.04
University of Oslo (UiO), Norway
0.500000
 0.04
University of Toronto (U of T), Canada
0.500000
 0.04
Interested in Oncology and Carcinogenesis?